« Back
Home /
LM22A-4

LM22A-4

€89.00

Excl. VAT

Item no.	HY-100673-10mg
Manufacturer	MedChem Express
CASRN	37988-18-4
Amount	10 mg
Category	Oncology Inhibitors & Compound Libraries Small Molecules By Organ Colorectal Cancer Testicular & Prostate Cancer
Type	Inhibitors
Specific against	other
Purity	98.53
Formula	C15H21N3O6
Citations	[1]Yu G, et al. Protective effects of LM22A-4 on injured spinal cord nerves. Int J Clin Exp Pathol. 2015 Jun 1;8(6):6526-32. eCollection 2015. [2]Kajiya M, et al. BDNF mimetic compound LM22A-4 regulates cementoblast differentiation via the TrkB-ERK/Akt signaling cascade. Int Immunopharmacol. 2014 Apr;19(2):245-52
Smiles	O=C(C1=CC(C(NCCO)=O)=CC(C(NCCO)=O)=C1)NCCO
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	37988-18-4
Available
Product Description	LM22A-4 is a specific agonist of tyrosine kinase receptor B, used for neurological disease research.
StorageTemperature	-20°C, 3 years; 4°C, 2 years (Powder)
Shipping	Room Temperature
Manufacturers Applications	Neuroscience-Neuromodulation
Molecular Weight	339.34
Clinical Information	No Development Reported
Solubility	DMSO : ≥ 29 mg/mL\|H2O : ≥ 50 mg/mL
Pathway	Neuronal Signaling; Protein Tyrosine Kinase/RTK
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-100673-10mg-safety-datasheet.pdf